Table 3 Effect of eradication status on ACR present change decrease in the whole H pylori study population and within each group.
Stool H.pylori Ag | P value | ||||
|---|---|---|---|---|---|
Negative | Positive | ||||
Median(IQR) | Range | Median(IQR) | Range | ||
ACR percent change decrease in the whole H pylori study population regardless drug type | 22.69(6.18- 34.38) | −13.54- 53.1 | 19.73(6.41- 30.74) | −21.58- 64.37 | 0.672 |
ACR percent change decrease within Vonoprazan group | 30.39(22.69–37.24) | −7.44-53.1 | 33.57(21.59–48.85) | 0.66–64.37 | 0.503 |
ACR percent change decrease within Lansoprazole group | 7.26(3.28–18.31) | −13.54-47.67 | 9.61(3.11–21.91) | −21.58-37.33 | 0.635 |
